Alpha Sense BI

FEBRUARY 3, 2023

But today, ESG has emerged as a business-as-usual topic, even amid uncertain global economic conditions. The Drivers Behind Change in ESG Investing The intentions behind ESG investing are altruistic: to influence the mainstream finance industry into funneling private capital to address global challenges.

Finance 98

Finance Due Diligence Banking Pharmaceutical 98

CIO

JANUARY 3, 2024

According to an Ernst & Young survey of 1,200 global CEOs released in late October, 99% are either planning or are already making “significant” investments in generative AI. That would give the smaller vendors time to innovate further, or give customers time to migrate. He’s not the only one. But it’s not exactly a safe bet.

Alliance 821

Alliance Due Diligence Pharmaceutical Technology 821

Alpha Sense BI

DECEMBER 15, 2023

From identifying potential drug candidates and optimizing molecular structures to streamlining clinical trial design and enhancing personalized medicine , this technology is driving unprecedented efficiency and innovation. The integration of these systems enhances operational efficiency, freeing scientists to focus on innovation.

Pharmaceutical 52

Pharmaceutical Algorithm Predictive Analytics Research 52

Alpha Sense BI

MARCH 13, 2024

According to PwC’s Annual Global CEO survey, 54% of healthcare industry CEOs intend to make at least one acquisition in the next three years. This emerging trend is allowing pharmaceutical companies—large and small—to distinguish themselves among competitors and investors as they pioneer advancements fueled by AI.

Pharmaceutical 59

Pharmaceutical Hospitals Due Diligence Biotech 59